$4.010
+0.199 (+4.97%)Al cierre
Noticias de PIII
Eventos de PIII
Selling Stockholders Plan to Sell 15.64M Shares of Class A Common Stock
This filing relates to the offer and sale from time to time by the selling stockholders of up to 15.64M shares of Class A common stock. The company is not selling any shares under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.
P3 Health Partners Appoints Dr. Michael Millie as Chief Clinical Officer
P3 Health Partners announced the appointment of Dr. Michael Millie as Chief Clinical Officer, effective October 12, 2026. Dr. Millie most recently served as a Chief Medical Officer, overseeing clinical and value-based care programs.
Sees FY26 Adjusted EBITDA of $80M-$110M
Sees FY26 adjusted EBITDA $80M-$110M.
P3 Reports Q2 Revenue of $386.38M, Beating Expectations
Reports Q2 revenue $386.38M, consensus $377.95M. "Q2 demonstrates that the business is now executing according to our plan. We delivered $54 million of adjusted EBITDA, with the core business driving improved profitability quarter over quarter. Our results reflect the structural improvements now embedded across our contracts, our network, and our operating model, the work I outlined at the onset of my tenure. That strength gives us the confidence to raise our full-year 2026 adjusted EBITDA outlook and to enter the second half focused on execution," said Dr. Aric Coffman, CEO of P3.
P3 Health Partners Inc Trading Resumes
P3 Health Partners Inc trading resumes
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.